| |
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect & identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, & state-of-the-art computer science & data science to enhance the scientific understanding of cancer biology, & to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, & the United Kingdom. GRAIL is a wholly-owned subsidiary of Illumina (NASDAQ:ILMN). For more information, please visit www.grail.com.
GRAIL is seeking a Partnership Account Director/Associate Director to become part of the Strategic Partnerships Team aligned to healthcare systems. This team is tasked with securing multi-year partnerships with marquee healthcare institutions across the US, driving the acceleration of evidence, to support multi-cancer early detection. The individual in this role will engage with executive leadership to establish partnerships dedicated to identifying co-developed initiatives to support evidence generation & innovation in the field of multi-cancer early detection. Candidates will be required to understand how to successfully navigate complex negotiations, develop meaningful account relations, & deliver high-value project concepts through contract execution. Partnership projects will span all areas of research, implementation science, population health, & real-world evidence generation. This role requires an exceptional understanding of the healthcare ecosystem, molecular diagnostics, & how to establish research initiatives that support GRAIL's mission to detect cancer early, when it can be cured. Without exception, this role requires a positive, team-based attitude that is ready to bring a new shift in healthcare that could impact patient outcomes globally.This role is remote based, with 50% travel expected.
| |
|
